Healthcare -
Biotechnology - NASDAQ - GB
$ 0.5799
-1.71 %
$ 148 M
Market Cap
-3.41
P/E
ADAP - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative ADAP - Adaptimmune Therapeutics plc
71.8 M
LAST VALUE
11.94%
2 YEAR CAGR
10.49%
5 YEAR CAGR
50.41%
10 YEAR CAGR